Curis Lifescien.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1BZN01016
  • NSEID: CURIS
  • BSEID:
INR
115.20
-8.2 (-6.65%)
BSENSE

Jan 19

BSE+NSE Vol: 1000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Markets Mojo
No Consolidated Results Declared by Curis Lifescien.
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Jun 2025 is 33.93%

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Jun 2025 is 39.64%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Jun 2025 is 26.96%

stock-summary

Interest

YoY Growth in nine months ended Jun 2025 is -8.86%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Jun 2025 has fallen from Jun 2025

Compare Nine Monthly Results Of Curis Lifescien. With
Figures in Cr
Markets Mojo
No Consolidated Results Declared by Curis Lifescien.
Nine Monthly - Net Sales
Net Sales 47.41 Cr
in Jun 2025

Figures in Cr
Nine Monthly - Standalone Net Profit
Standalone Net Profit 7.08 Cr
in Jun 2025

Figures in Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.22 Cr
in Jun 2025

Figures in Cr
Nine Monthly - Interest
Interest 0.72 Cr
in Jun 2025

Figures in Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.56%
in Jun 2025

Figures in %